PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer

NCT03774732 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

327

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer
Non Small Cell Lung Cancer Metastatic
Non-Small Cell Carcinoma of Lung, TNM Stage 4

Interventions

RADIATION: Radiotherapy
DRUG: Pembrolizumab
DRUG: Chemotherapy

Sponsor

UNICANCER

Collaborators

[object Object]